Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1060568

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Imports
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to make it his policy to subject imported products to the same (a) targets and (b) labelling requirements with respect to calorie reduction regulations as those required of UK manufacturers.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	220924
answer	answer is ministerial correction date of answer 22/02/2019 answer text <p>The calorie reduction programme that Public Health England (PHE) oversees on behalf of Government challenges all sectors of industry to achieve a 20% reduction in calories in key foods contributing significantly to intakes of children up to 18 years by 2024. The programme is at an early stage with stakeholders having been consulted on initial draft proposed guidelines only in autumn 2018. No decisions have been taken at this stage of development on the guidelines and whether or how these will apply to imported products. PHE is considering the points raised through the consultation and is aiming to publish the guidelines in mid-2019.</p><p>In March 2017 PHE published guidance to assist local authorities in supporting and working with small businesses on voluntary reduction initiatives including calories. This guidance is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/encouraging-healthier-out-of-home-food-provision" target="_blank">https://www.gov.uk/government/publications/encouraging-healthier-out-of-home-food-provision</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 220925 question first answered 22/02/2019 14:56:10 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green

1060569

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to support small businesses to prepare for the new calorie reduction regulations that Public Health England are introducing.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	220925
answer	answer is ministerial correction date of answer 22/02/2019 answer text <p>The calorie reduction programme that Public Health England (PHE) oversees on behalf of Government challenges all sectors of industry to achieve a 20% reduction in calories in key foods contributing significantly to intakes of children up to 18 years by 2024. The programme is at an early stage with stakeholders having been consulted on initial draft proposed guidelines only in autumn 2018. No decisions have been taken at this stage of development on the guidelines and whether or how these will apply to imported products. PHE is considering the points raised through the consultation and is aiming to publish the guidelines in mid-2019.</p><p>In March 2017 PHE published guidance to assist local authorities in supporting and working with small businesses on voluntary reduction initiatives including calories. This guidance is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/encouraging-healthier-out-of-home-food-provision" target="_blank">https://www.gov.uk/government/publications/encouraging-healthier-out-of-home-food-provision</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 220924 question first answered 22/02/2019 14:56:10 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green

1060575

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Ethnic Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the stigma faced by BAME people living with HIV to help ensure they engage with medical professionals.
tabling member constituency	Lanark and Hamilton East
tabling member printed	Angela Crawley
uin	220955
answer	answer is ministerial correction date of answer 22/02/2019 answer text <p>In 2015, Public Health England (PHE) collaborated with the sexual health charity, the Family Planning Association, on the ‘People Living with HIV Stigma Survey UK’ to identify the stigma and discrimination experienced by people living with HIV in healthcare settings, faith settings, the workplace, and with intimate partners, family and friends. Results were disseminated via scientific manuscripts, medical conferences, and publicly available reports. Positive Voices, a recurring, nationally representative survey of people living with HIV, was last undertaken by PHE in 2017. It included questions on stigma and discrimination in healthcare settings. Dissemination of results is ongoing, including a community-led report on stigma: ‘Changing Perceptions: Talking about HIV and Attitudes’, and the production of publicly available reports, local reports, presentations and scientific manuscripts. These reports aim to change perceptions about living with HIV.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/02/2019 08:05:27 answering member 4067 label Biography information for Steve Brine
tabling member	4469 label Biography information for Angela Crawley

1060578

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what analysis the National Institute for Clinical Excellence has undertaken on companies' ability to pay the proposed charges for making technology appraisals and highly specialised technology recommendations.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	220926
answer	answer is ministerial correction date of answer 20/02/2019 answer text <p>The introduction of charges is intended to create a sustainable funding model for the National Institute for Health and Care Excellence’s (NICE) technology appraisal and highly specialised technologies programmes that better positions it to adapt to future changes in the life sciences sector. The Government carried out a public consultation on the introduction of charges and took full account of the comments received in deciding to proceed. The Government response to the consultation and the Impact Assessment, published alongside the regulations, assess the impact of the introduction of charging on all relevant stakeholders, including the life sciences industry and NICE. As explained in the Government response and Impact Assessment, small companies whose products are undergoing assessment will benefit from a 75% discount, which is intended to minimise barriers to the participation of small companies. The Government response is available at the following link:</p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/762725/government-response-to-nice-recommendations-consultation.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/762725/government-response-to-nice-recommendations-consultation.pdf</a></p><p> </p><p>The Impact Assessment at is available at the following link:</p><p> </p><p><a href="http://www.legislation.gov.uk/ukia/2018/171/pdfs/ukia_20180171_en.pdf" target="_blank">http://www.legislation.gov.uk/ukia/2018/171/pdfs/ukia_20180171_en.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 220258 220261 220262 question first answered 20/02/2019 17:30:49 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green

1060592

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many weeks’ worth of medicines the Government has asked pharmaceutical companies to stockpile as part of preparations for the UK leaving the EU without a deal; and how his Department decided on that period of duration.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	220998
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 221000 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
tabling member	4610 label Biography information for Bambos Charalambous

1060593

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has in place to (a) (i) monitor and (ii) identify gaps in the medicines being stockpiled by pharmaceutical companies and (b) protect the supply of medicines not being stockpiled by pharmaceutical companies.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	220999
answer	answer is ministerial correction date of answer 22/02/2019 answer text <p>In August 2018, the Department asked suppliers to confirm arrangements in respect of prescription-only and pharmacy medicines that come from or via the European Union /European Economic Area. Company responses have provided the Department with an indication of industry’s ability and preparedness to stockpile six weeks’ worth of additional supply of each of the in-scope medicines in the United Kingdom ahead of 29 March 2019.</p><p>Since then, we have continued to receive very good engagement and are working closely with industry on a product-by-product basis. Companies share our aims of ensuring continuity of medicines supply for patients is maintained and that suppliers are able to cope with any potential delays at the border that may arise in the short term in a ‘no deal’ scenario.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 22/02/2019 11:59:04 answering member 1585 label Biography information for Stephen Hammond
tabling member	4610 label Biography information for Bambos Charalambous

1060594

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information he holds on those NHS breast cancer drugs that pharmaceutical companies will have six weeks' supply of by 29 March 2019.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	221000
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220998 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
tabling member	4610 label Biography information for Bambos Charalambous

1060618

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Brexit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the cost to the public purse of his Department's preparations for the UK leaving the EU without a deal.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	220768
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Of the £71.1 million funding the Department has been allocated for 2018/19 and 2019/20 for preparations for European Union exit, we are unable to provide a breakdown of the amount of funding allocated to ‘no deal’ preparations specifically, as this cannot be separated from EU exit work as a whole across the Department.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:21:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	308 label Biography information for Mr Jim Cunningham

1060620

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, what advice he has for people on kidney dialysis who wish to travel in the EU or EEA and to whom his advice of 28 January 2019 does not cover because dialysis is not covered under travel insurance.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220902
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220903 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott

1060621

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, when he will issue an update to that advice for people on kidney dialysis who wish to travel to the EU or EEA.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220903
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220902 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott